A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 5934-5940

  Goleva, Elena ^a   Kisich, Kevin O ^a   Leung, Donald Y M ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 4; JANUS ASSOCIATED KINASE 3 INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL LINE; CELL NUCLEUS; DRUG SENSITIVITY; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPLEEN CELL;

EID: 0037111418     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.5934     Document Type: Article

References (37)

1. Honda, M., F. Orii, T. Ayabe, S. Imai, T. Ashida, T. Obara, and Y. Kohgo. 2000. Expression of glucocorticoid receptor β in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118:859.
2. Hammond, J. M., and E. D. Bateman. 1990. Successful treatment of life-threatening steroid-resistant pulmonary sarcoidosis with cyclosporin in a patient with systemic lupus erythematosus. Respir. Med. 84:77.
3. Coman, E., and J. F. Reinus. 1990. Cyclosporine use in steroid-resistant Crohn's disease: Grasping at new straws? Am. J. Gastroenterol. 85:758.
4. Langhoff, E., J. Ladefoged, B. K. Jakobsen, P. Platz, L. P. Ryder, A. Svejgaard, and J. H. Thaysen. 1986. Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival. Lancet 1:1296.
5. Leung, D. Y., R. J. Martin, S. J. Szefler, E. R. Sher, S. Ying, A. B. Kay, and Q. Hamid. 1995. Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma. J. Exp. Med. 181:33.
6. Kino, T., and G. P. Chrousos. 2002. Tissue-specific glucocorticoid resistance-hypersensitivity syndromes: Multifactorial states of clinical importance. J. Allergy Clin. Immunol. 109:609.
7. Leung, D. Y., and G. P. Chrousos. 2000. Is there a role for glucocorticoid receptor β in glucocorticoid-dependent asthmatics? Am. J. Respir. Crit. Care Med. 162:1.
8. Hecht, K., J. Carlstedt-Duke, P. Stierna, J. Gustafsson, M. Bronnegard, and A. C. Wikstrom. 1997. Evidence that the β-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J. Biol. Chem. 272:26659.
9. Sher, E. R., D. Y. Leung, W. Surs, J. C. Kam, G. Zieg, A. K. Kamada, and S. J. Szefler. 1994. Steroid-resistant asthma: Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J. Clin. Invest. 93:33.
10. Kam, J. C., S. J. Szefler, W. Surs, E. R. Sher, and D. Y. Leung. 1993. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J. Immunol. 151:3460.
11. Otto, C., H. M. Reichardt, and G. Schutz. 1997. Absence of glucocorticoid receptor-β in mice. J. Biol. Chem. 272:26665.
12. Zubiaga, A. M., E. Munoz, and B. T. Huber. 1992. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J. Immunol. 149: 107.
13. Bertoglio, J. H., and E. Leroux. 1988. Differential effects of glucocorticoids on the proliferation of a murine helper and a cytolytic T cell clone in response to IL-2 and IL-4. J. Immunol. 141:1191.
14. Cetkovic-Cvrlje, M., B. A. Roers, B. Waurzyniak, X. P. Liu, and F. M. Uckun. 2001. Targeting Janus kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice. Blood 98:1607.
15. Tibbles, H. E., A. Vassilev, H. Wendorf, D. Schonhoff, D. Zhu, D. Lorenz, B. Waurzyniak, X. P. Liu, and F. M. Uckun. 2001. Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation. J. Biol. Chem. 276:17815.
16. Irusen, E., J. G. Matthews, A. Takahashi, P. J. Barnes. K. F. Chung, and I. M. Adcock. 2002. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma. J. Allergy Clin. Immunol. 109:649.
17. Strickland, I., K. Kisich, P. J. Hauk, A. Vottero, G. P. Chrousos, D. J. Klemm, and D. Y. Leung. 2001. High constitutive glucocorticoid receptor β in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J. Exp. Med. 193:585.
18. Leung, D. Y., Q. Hamid, A. Vottero, S. J. Szefler, W. Surs, E. Minshall, G. P. Chrousos, and D. J. Klemm. 1997. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J. Exp. Med. 186: 1567.
19. Hauk, P. J., E. Goleva, J. Gutierrez, I. Strickland, A. Vottero, G. P. Chrousos, K. O. Kisich, and D. Y. M. Leung. 2002. Increased glujcocorticoid receptor β expression converts mouse hybridoma cells to a corticosteroid insensitive phenotype. Am. J. Respir. Cell Mol. Biol. 27:361.
20. Gougat, C., D. Jaffuel, R. Gagliardo, C. Henriquet, J. Bousquet, P. Demoly, and M. Mathieu. 2002. Overexpression of the human glucocorticoid receptor α and β isoforms inhibits AP-1 and NF-κB activities hormone independently. J. Mol. Med. 80:309.
21. Barnes, P. J. 1997. Molecular mechanisms of glucocorticoid action in asthma. Pulm. Pharmacol. Ther. 10:3.
22. McKay, L. I., and J. A. Cidlowski. 1999. Molecular control of immune/inflammatory responses: Interactions between nuclear factor-κB and steroid receptor-signaling pathways. Endocr. Rev. 20:435.
23. Karin, M., and L. Chang. 2001. AP-1-glucocorticoid receptor crosstalk taken to a higher level. J. Endocrinol. 169:447.
24. Gesbert, F., M, Delespine-Carmagnat, and J. Bertoglio. 1998. Recent advances in the understanding of interleukin-2 signal transduction. J. Clin. Immunol. 18:307.
25. Imada, K., and W. J. Leonard. 2000. The Jak-STAT pathway. Mol. Immunol. 37:1.
26. Lin, J. X., and W. J. Leonard. 2000. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19:2566.
27. Leonard, W. J., and J. J. O'Shea. 1998. Jaks and STATs: Biological implications. Annu. Rev. Immunol. 16:293.
28. 694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J. 13:4361.
29. Shuai, K. 2000. Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19:2638.
30. Wyszomierski, S. L., J. Yeh, and J. M, Rosen. 1999. Glucocorticoid receptor/ signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol. Endocrinol. 13:330.
31. Stocklin, E., M. Wissler, F. Gouilleux, and B. Groner. 1996. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726.
32. Biola, A., K. Andreau, M. David, M. Sturm, M. Haake, J. Bertoglio, and M. Pallardy. 2000. The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes. FEBS Lett. 487:229.
33. Aittomaki, S., M. Pesu, B. Groner, O. A. Janne, J. J. Palvimo, and O. Silvennoinen. 2000. Cooperation among STAT1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fcγ receptor I in monocytes. J. Immunol. 164:5689.
34. Biola, A., P. Lefebvre, M. Perrin-Wolff, M. Sturm, J. Bertoglio, and M. Pallardy. 2001. lnterleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1. Mol. Endocrinol. 15:1062.
35. Wang, Z., J. Frederick, and M. J. Garabedian. 2002. Deciphering the phosphorylation code of the glucocorticoid receptor in vivo. J. Biol. Chem. 277:26573.
36. Savory, J. G., B. Hsu, I. R. Laquian, W. Giffin, T. Reich, R. J. Hache, and Y. A. Lefebvre. 1999. Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol. Cell. Biol. 19:1025.
37. Doppler, W., M. Windegger, C. Soratroi, J., Tomasi, J. Lechner, S. Rusconi, A. C. Cato, T. Almlof, J. Liden, S. Okret, et al. 2001. Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5. Mol. Cell. Biol. 21:3266.